Interrelationships between inflammation, C-reactive protein, and insulin resistance (Q36902768)

17 August 2017

1 reference

title

Interrelationships between inflammation, C-reactive protein, and insulin resistance (English)

1 reference

17 August 2017

1 reference

3

Paul M Ridker

1 reference

17 August 2017

2

Aruna D Pradhan

1 reference

17 August 2017

Chiadi E Ndumele

1

1 reference

17 August 2017

1 January 2006

1 reference

Journal of the cardiometabolic syndrome

17 August 2017

1 reference

17 August 2017

1

1 reference

17 August 2017

3

1 reference

17 August 2017

190-196

1 reference

Atherosclerosis — An Inflammatory Disease

17 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

C-reactive protein and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Acute-phase proteins and other systemic responses to inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

The insulin signalling system and the IRS proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Preadipocyte conversion to macrophage. Evidence of plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Nitric oxide-induced expression of C-reactive protein in islet cells as a very early marker for islet stress in the rat pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Differentiation between obesity and insulin resistance in the association with C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

C-Reactive Protein Is Independently Associated With Fasting Insulin in Nondiabetic Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Urinary albumin excretion is independently associated with C-reactive protein levels in overweight and obese nondiabetic premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Can exercise training with weight loss lower serum C-reactive protein levels?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Effect of rosiglitazone on insulin resistance, C-reactive protein and endothelial function in non-obese young women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Effects of rosiglitazone on endothelial function, C-reactive protein, and components of the metabolic syndrome in nondiabetic patients with the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Intensive Insulin Therapy Exerts Antiinflammatory Effects in Critically Ill Patients and Counteracts the Adverse Effect of Low Mannose-Binding Lectin Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

Radiolabeled Native Low-Density Lipoprotein Injected Into Patients With Carotid Stenosis Accumulates in Macrophages of Atherosclerotic Plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05538.X

10.1111/J.1559-4564.2006.05538.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17679826